ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 27 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $94 | -5.1% | 313,300 | +9.2% | 0.00% | – |
| Q2 2023 | $99 | -50.5% | 287,000 | +12.5% | 0.00% | – |
| Q1 2023 | $200 | -17.4% | 255,100 | +5.5% | 0.00% | – |
| Q4 2022 | $242 | -100.0% | 241,800 | -75.3% | 0.00% | -100.0% |
| Q3 2022 | $874,000 | +22.2% | 979,800 | +52.2% | 0.00% | 0.0% |
| Q2 2022 | $715,000 | -5.4% | 643,734 | +18.4% | 0.00% | 0.0% |
| Q1 2022 | $756,000 | -11.6% | 543,800 | +44.4% | 0.00% | 0.0% |
| Q4 2021 | $855,000 | +43.7% | 376,532 | +163.7% | 0.00% | 0.0% |
| Q3 2021 | $595,000 | +139.9% | 142,805 | +173.6% | 0.00% | – |
| Q2 2021 | $248,000 | -48.7% | 52,200 | -47.0% | 0.00% | -100.0% |
| Q4 2020 | $483,000 | +92.4% | 98,569 | -33.3% | 0.00% | – |
| Q3 2020 | $251,000 | +30.1% | 147,683 | +117.0% | 0.00% | – |
| Q2 2020 | $193,000 | +141.2% | 68,048 | +149.1% | 0.00% | – |
| Q1 2020 | $80,000 | -3.6% | 27,317 | +30.2% | 0.00% | – |
| Q4 2019 | $83,000 | – | 20,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 1,256,717 | $3,569,000 | 0.16% |
| DOWLING & YAHNKE LLC | 150,464 | $427,000 | 0.04% |
| Aureus Asset Management, LLC | 70,211 | $199,000 | 0.02% |
| IEQ CAPITAL, LLC | 72,217 | $205,000 | 0.01% |
| Cohen Capital Management, Inc. | 13,046 | $37,000 | 0.01% |
| Creative Planning | 487,737 | $1,385,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 84,605 | $240,000 | 0.00% |
| North Star Investment Management Corp. | 4,000 | $11,000 | 0.00% |
| DELTA ASSET MANAGEMENT LLC/TN | 7 | $0 | 0.00% |
| MORGAN STANLEY | 21,342 | $61,000 | 0.00% |